Actively Recruiting
Study of Late-foetal Human Organ Development
Led by University College London Hospitals · Updated on 2023-12-05
2000
Participants Needed
1
Research Sites
986 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Knowledge about abnormal organ development is important to understand pathology and to develop novel treatment approaches for individuals with congenital and acquired disease. Most of our current understanding is based on examination of tissues from the embryo and early fetus, collected from women undergoing termination of pregnancy in the first trimester (third) of pregnancy. There is very little known about normal and abnormal organ development from a developmental perspective during the crucial last two-thirds of pregnancy when much remodelling of fetal tissues occurs. We aim to collect tissue from a variety of developing fetal organs in the last two-thirds of pregnancy from women who decide to undergo a termination of pregnancy and who wish to undergo a clinical fetal postmortem (PM) examination.
CONDITIONS
Official Title
Study of Late-foetal Human Organ Development
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant women aged 18 years or older who attend the Fetal Medicine Unit for concerns about a fetal abnormality and decide to proceed with termination of pregnancy
You will not qualify if you...
- Positive screening labs for maternal HIV, Hepatitis B, Hepatitis C, Chlamydia, or Herpes
- Unable to make an informed decision about termination of pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University College Hospitals NHS Foundation Trust
London, United Kingdom
Actively Recruiting
Research Team
S
Sarah Gibbon
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here